192 related articles for article (PubMed ID: 35957875)
1. CEMIP Promotes Osteosarcoma Progression and Metastasis Through Activating Notch Signaling Pathway.
Cheng J; Zhang Y; Wan R; Zhou J; Wu X; Fan Q; He J; Tan W; Deng Y
Front Oncol; 2022; 12():919108. PubMed ID: 35957875
[TBL] [Abstract][Full Text] [Related]
2. LncRNA LINC00958 promotes tumor progression through miR-4306/CEMIP axis in osteosarcoma.
Zhou Y; Mu T
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3182-3199. PubMed ID: 33928604
[TBL] [Abstract][Full Text] [Related]
3. The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse Signaling.
Yu L; Xia K; Gao T; Chen J; Zhang Z; Sun X; Simões BM; Eyre R; Fan Z; Guo W; Clarke RB
Mol Cancer Res; 2019 Dec; 17(12):2383-2394. PubMed ID: 31570655
[TBL] [Abstract][Full Text] [Related]
4. Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway.
Sim I; Choe W; Ri J; Su H; Moqbel SAA; Yan W
Med Oncol; 2023 Sep; 40(10):294. PubMed ID: 37668818
[TBL] [Abstract][Full Text] [Related]
5. CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway.
Shen F; Zong ZH; Liu Y; Chen S; Sheng XJ; Zhao Y
Biomed Pharmacother; 2019 Jun; 114():108787. PubMed ID: 30925458
[TBL] [Abstract][Full Text] [Related]
6. Cell migration inducing hyaluronidase 1 promotes growth and metastasis of papillary thyroid carcinoma.
Zhou M; Hua W; Sun Y
Bioengineered; 2022 May; 13(5):11822-11831. PubMed ID: 35543351
[TBL] [Abstract][Full Text] [Related]
7. Notch signaling regulates osteosarcoma proliferation and migration through Erk phosphorylation.
Qin J; Wang R; Zhao C; Wen J; Dong H; Wang S; Li Y; Zhao Y; Li J; Yang Y; He X; Wang D
Tissue Cell; 2019 Aug; 59():51-61. PubMed ID: 31383289
[TBL] [Abstract][Full Text] [Related]
8. Critical role of notch signaling in osteosarcoma invasion and metastasis.
Zhang P; Yang Y; Zweidler-McKay PA; Hughes DP
Clin Cancer Res; 2008 May; 14(10):2962-9. PubMed ID: 18483362
[TBL] [Abstract][Full Text] [Related]
9. CEMIP regulates the proliferation and migration of vascular smooth muscle cells in atherosclerosis through the WNT-beta-catenin signaling pathway.
Xue Q; Wang X; Deng X; Huang Y; Tian W
Biochem Cell Biol; 2020 Apr; 98(2):249-257. PubMed ID: 32207314
[TBL] [Abstract][Full Text] [Related]
10. A novel metastatic promoter CEMIP and its downstream molecular targets and signaling pathway of cellular migration and invasion in SCLC cells based on proteome analysis.
Li L; Pan Y; Mo X; Wei T; Song J; Luo M; Huang G; Teng C; Liang K; Mao N; Yang J
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2519-2534. PubMed ID: 32648226
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.
Pan BL; Wu L; Pan L; Yang YX; Li HH; Dai YJ; He ZQ; Tan L; Huang YG; Tong ZW; Liao JL
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769415
[TBL] [Abstract][Full Text] [Related]
12. CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway.
Xu G; Zhao L; Hua Q; Wang L; Liu H; Lin Z; Jin M; Wang J; Zhou P; Yang K; Wu G; Yu D; Zhang D; Zhang T
Cell Death Dis; 2023 Feb; 14(2):167. PubMed ID: 36849460
[TBL] [Abstract][Full Text] [Related]
13. Cell migration inducing hyaluronidase 1 (CEMIP) activates STAT3 pathway to facilitate cell proliferation and migration in breast cancer.
Chen Y; Li L; Zhang J
J Recept Signal Transduct Res; 2021 Apr; 41(2):145-152. PubMed ID: 32757700
[TBL] [Abstract][Full Text] [Related]
14. CEMIP, a Promising Biomarker That Promotes the Progression and Metastasis of Colorectal and Other Types of Cancer.
Domanegg K; Sleeman JP; Schmaus A
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291875
[TBL] [Abstract][Full Text] [Related]
15. AMPK/GSK3β/β-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming.
Zhang P; Song Y; Sun Y; Li X; Chen L; Yang L; Xing Y
FASEB J; 2018 Jul; 32(7):3924-3935. PubMed ID: 29505302
[TBL] [Abstract][Full Text] [Related]
16. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.
Hughes DP
Cancer Treat Res; 2009; 152():479-96. PubMed ID: 20213410
[TBL] [Abstract][Full Text] [Related]
17. CEMIP promotes small cell lung cancer proliferation by activation of glutamine metabolism via FBXW7/c-Myc-dependent axis.
Mo X; Shen X; Mo X; Yu F; Tan W; Deng Z; He J; Luo Z; Chen Z; Yang J
Biochem Pharmacol; 2023 Mar; 209():115446. PubMed ID: 36746261
[TBL] [Abstract][Full Text] [Related]
18. CEMIP-mediated hyaluronan metabolism facilitates SCLC metastasis by activating TLR2/c-Src/ERK1/2 axis.
Li L; Shen X; Mo X; Chen Z; Yu F; Mo X; Song J; Huang G; Liang K; Luo Z; Mao N; Yang J
Biochim Biophys Acta Mol Cell Res; 2023 Jun; 1870(5):119451. PubMed ID: 36931608
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway.
Wu F; Zhang FY; Tan GQ; Chen WJ; Huang B; Yan L; Zhang HL; Chen S; Jiao Y; Wang BL
BMC Cancer; 2021 Jun; 21(1):704. PubMed ID: 34130659
[TBL] [Abstract][Full Text] [Related]
20. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
